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To infect a cell, the Paramyxoviridae family of enveloped viruses
relies on the coordinated action of a receptor-binding protein (var-
iably HN, H, or G) and a more conserved metastable fusion protein
(F) to effect membrane fusion and allow genomic transfer. Upon
receptor binding, HN (H or G) triggers F to undergo an extensive
refolding event to form a stable postfusion state. Little is known
about the intermediate states of the F refolding process. Here,
a soluble form of parainfluenza virus 5 F was triggered to refold
using temperature and was footprinted along the refolding path-
way using fast photochemical oxidation of proteins (FPOP). Local-
ization of the oxidative label to solvent-exposed side chains was
determined by high-resolution MS/MS. Globally, metastable pre-
fusion F is oxidized more extensively than postfusion F, indicating
that the prefusion state is more exposed to solvent and is more
flexible. Among the first peptides to be oxidatively labeled after
temperature-induced triggering is the hydrophobic fusion peptide.
A comparison of peptide oxidation levels with the values of sol-
vent-accessible surface area calculated from molecular dynamics
simulations of available structural data reveals regions of the F
protein that lie at the heart of its prefusionmetastability. The strong
correlation between the regions of F that experience greater-than-
expected oxidative labeling and epitopes for neutralizing anti-
bodies suggests that FPOP has a role in guiding the development
of targeted therapeutics. Analysis of the residue levels of labeled F
intermediates provides detailed insights into the mechanics of this
critical refolding event.
protein refolding | viral fusion protein | mass spectroscopy
The Paramyxoviridae family of enveloped viruses includes manymedically and economically important pathogens (1). This
large family of negative-sense, single-stranded RNA viruses
includes measles virus (MeV), mumps virus, human parainfluenza
viruses 1–4 (hPIV1–4), parainfluenza virus 5 (PIV5, formerly
known as simian virus 5, SV5), human respiratory syncytial virus
(hRSV), human metapneumovirus (hMPV), Newcastle disease
virus (NDV), Sendai virus, and canine distemper virus (CDV).
Newly discovered and highly pathogenic paramyxoviruses in-
clude the zoonotic Nipah and Hendra viruses. The recent dis-
covery of 66 unique mammalian paramyxovirus sequences from
bats and rodents (2) suggests that the impact of this virus family
on human health will continue to grow.
Paramyxoviruses, like all enveloped viruses, possess a lipid
bilayer that is derived from the host cell during viral egress.
Paramyxovirus particles must fuse their membrane with the
membrane of a target host cell for successful infection to occur.
Embedded in the viral envelope are the viral spike glycoproteins
necessary for receptor binding and fusion with a target cell. The
receptor-binding and fusion activities are carried out by a vari-
able attachment protein, known as “HN,” “H,” or “G” protein,
and a more conserved fusion (F) protein, respectively (3–5).
Coexpression of HN, H, or G and the F protein in the same cell
is required to activate the F protein, and coimmunoprecipitation
data indicate F and HN, H, or G interact physically through the
HN, H, or G stalk region (5–13). Receptor specificity of the
attachment protein (14–19) ensures that the F protein is acti-
vated at the correct time and place for a successful invasion of
a target cell. Although F protein activation is mediated naturally
via interaction with the HN, H, or G stalk domain in most
paramyxovirus species (20–27), increased temperature can be
used as a surrogate trigger for PIV5, CDV, and MeV F proteins
(24, 28–32). F proteins from different paramyxoviruses have
different energy requirements for activation (24, 29, 33, 34).
Paramyxovirus F proteins, together with influenza virus HA,
Ebola virus GP, and HIV Env, among others, are classified as
class I viral fusion proteins (35). Class I fusion proteins share the
following characteristics: all are trimers, all initially fold in the
endoplasmic reticulum into a metastable “prefusion” confor-
mation, and all are synthesized as a precursor that must be
cleaved to generate a new N terminus that is hydrophobic and
known as the “fusion peptide” (FP). Cleavage usually is required
for membrane fusion, viral infectivity, and pathogenicity (36–39).
The current model of class I fusion protein function posits that
the metastable F protein, upon activation by HN, H, or G,
undergoes a series of large-scale refolding events, going down an
energy gradient from a metastable prefusion form to a final,
stable postfusion form (reviewed in refs. 3, 5, and 40). The work
done in refolding brings the lipid bilayers in close proximity so
that membrane merger (fusion) can occur. Atomic structures
have been obtained for PIV5 and hRSV F proteins in the
prefusion form (41–43) and for hPIV3, NDV, and hRSV F
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proteins in the postfusion form (44–47). Together with bio-
chemical data and EM images (11, 48, 49), these data give in-
sight into the refolding process. However, detailed information
derived directly from experimental data is lacking for the
intermediate states.
It is thought that the heptad repeat B (HRB) region of the F
protein (Fig. 1A), which comprises the prefusion stalk (Fig. 1B),
opens upon triggering by receptor-bound HN, H, or G (48). This
change allows the rearrangement and extension of the heptad
repeat A (HRA) region at the top of the protein into an ex-
tended α-helical coiled-coil. The HRA coiled-coil inserts its at-
tached N-terminal hydrophobic FP into the target membrane,
extending 22 nm between the virus and the target cell (49) to give
a transient intermediate structure of F, which is called the
“prehairpin intermediate.” The F trimer then begins to fold back
on itself, drawing the viral and host cell membranes together.
The energy required to desolvate the membranes and then
subsequently fuse them together is provided by the formation of
the highly stable six-helix bundle (6HB) structure (Fig. 1C) (50,
51). Once the viral membrane has fused with the membrane of
the target cell, the viral genome can enter the cytoplasm, and
replication can begin. However, with the exception of the start-
ing point (prefusion) and endpoint (postfusion) atomic struc-
tures for a handful of viral fusion proteins, little is known about
the structural details of the intermediates in this critical process.
To determine the solvent exposure of different regions of the
prefusion F protein, we oxidatively labeled a soluble form of the
PIV5 F protein (F-GCNt) during its transition along the fusion-
refolding pathway using fast photochemical oxidation of proteins
(FPOP). FPOP uses a pulsed 248-nm wavelength laser to gen-
erate •OH free radicals from molecular H2O2 to create a brief
(∼1 μs) but intense oxidizing pulse around the protein of interest
(52). The short-lived free radicals covalently react with and
modify solvent-exposed side chains of the protein, which sub-
sequently are detected by high-resolution MS. The duration of
the oxidizing pulse is modulated through a carefully titrated
amount of a free radical scavenger (e.g., glutamine) so that na-
tive surfaces exposed through protein “breathing” are labeled
but surfaces exposed by oxidation-induced unfolding are not
labeled because the radicals are quenched within 1 μs. Location
of the oxidative modifications follows tryptic digestion of the
protein and analysis of the resulting peptides by high perfor-
mance liquid chromatography and tandem mass spectrometry
(HPLC-MS/MS). We show here the regions of PIV5 F-GCNt (as
represented by tryptic peptides) that are more susceptible to free
radical oxidation in the prefusion state than in the postfusion
protein, likely reflecting the less stable, less compact nature of
the prefusion state. The F refolding process was monitored at the
peptide and residue levels, permitting the creation of a detailed
model of the refolding event and enabling the detection of sol-
vent-accessible and likely flexible regions of the prefusion F
trimer that may lie at the heart of the F protein metastability.
Additionally, values for the theoretical solvent-accessible sur-
face area (SASA) were calculated for each residue from 10-ns
molecular dynamics (MD) simulations of the static prefusion
PIV5 F state [Protein Data Bank (PDB) ID code 2B9B] (Fig. 1B)
and of a model based on the postfusion hPIV3 crystal structure
(PDB ID code 1ZTM) (Fig. 1C). A comparison of the calculated
SASA values and experimental FPOP oxidation prefusion-to-
postfusion trends highlights regions of the protein with enhanced
solvent exposure not predicted by analysis of static crystal struc-
tures alone. The strong correlation between peptides exhibiting
greater-than-predicted FPOP oxidation in the prefusion state and
neutralizing antibody epitopes may highlight functionally signifi-
cant regions of the prefusion viral fusion protein and thus may
guide the development of novel antiviral therapeutics. The work
presented here also illustrates how FPOP can be used to study the
dynamics of proteins and complexes that are difficult or impossible
to study by X-ray crystallography, NMR, or hydrogen-deuterium
exchange MS (HDX-MS).
Results
Oxidative Footprinting of PIV5 F Protein. We purified F-GCNt,
a soluble form of prefusion PIV5 F, that had been used pre-
viously to determine the atomic structures of both the uncleaved
(41) and the cleavage-activated (42) prefusion states of PIV5 F.
Postfusion PIV5 F-GCNt was prepared by heating prefusion
protein to 60 °C for 10 min and then storing the protein at 4 °C
until needed, as described previously (28). All prefusion and
postfusion F-GCNt samples were oxidatively labeled at 21 °C
using a modification of a previously described FPOP protocol
(52, 53) (see Fig. S1 for a diagram of the FPOP setup and Fig. S2
for an example of the data analysis).
Differences in FPOP labeling between the pre- and postfusion
states of PIV5 F were readily apparent from the oxidation data
(Fig. 2A), which showed more extensive oxidation of F-GCNt
in the prefusion state. The changes in FPOP labeling are more
clearly illustrated by mapping the oxidation data onto the atomic
structures of prefusion PIV5 F (Fig. 2B) and a homology model
based on the structure of postfusion hPIV3 F (Fig. 2C). Al-
though an atomic structure for postfusion PIV5 F is not avail-
able, a structural alignment of NDV F (45), RSV F (47), and
hPIV3 F (44) proteins in their postfusion states suggests that
the postfusion state is highly conserved among paramyxoviruses
(Fig. S3). Thus, the atomic structure of hPIV3 F in the postfusion
state was used as a template to create a homology model of post-
fusion PIV5 F (see Materials and Methods for further details of
homology model construction).
In 14 of 22 tryptic peptides detected in F-GCNt (representing
68% of the primary sequence) the extent of oxidation differs
significantly in the prefusion and postfusion states (Fig. 2A,
starred peptides; significance determined by a two-tailed Student
t test corrected for multiple hypothesis testing). Of these 14
peptides with different levels of oxidation, nine peptides (rep-
resenting 47% of the total primary sequence) were more ex-
tensively oxidized in the prefusion state. The decrease in
oxidation going from prefusion to postfusion is highlighted by
peptides that form a strap-like structure connecting Domain I
(DI) and Domain III (DIII) (peptides 37–52, 273–308, and 309–
334, marked by arrowheads in Fig. 2 B and C). In contrast, the
hydrophobic FP, consisting of overlapping peptides 102–129 and
Fig. 1. Organization of the trimeric, soluble PIV5 F protein. (A) The domain
organization of PIV5 F-GCNt, with a unique color for each domain. Corre-
sponding amino acid residues are noted below each segment. (B and C) The
prefusion crystal structure of PIV5 F (PDB ID code 2B9B) (B) and the post-
fusion crystal structure of hPIV3 F (PDBID code 1ZTM) (C), colored as in A. In
both B and C, two of the protomers are represented as semitransparent
surfaces; the third protomer is depicted as a ribbon cartoon. Highlighted
structural elements include HRA and HRB, the 6HB, and the hydrophobic FP,
which is disordered in the postfusion crystal structure.















103–129, exhibited an increase in FPOP oxidation consistent
with a transition from being sequestered in the prefusion state
(Fig. 2B, black arrow) to being exposed in the postfusion state
(Fig. 2C, black arrow). Similar results obtained for the two
overlapping peptides add credence to the approach.
A comparison of peptide SASA values calculated from 10-ns
MD simulations of the prefusion and homology postfusion PIV5
F-GCNt structures suggests that the solvent accessibility of most
regions of the protein, as represented by its tryptic peptides, does
not change dramatically between the states (Fig. S4). This ob-
servation is in contrast to the experimental FPOP data, which
show that the prefusion state is more accessible to solvent than
the postfusion state. However, because of protein size and
computational constraints, the backbone of F-GCNt was par-
tially restricted in its movement over the course of the 10-ns
simulation (see Movies S1 and S2). Thus, the calculated SASA
values may underestimate the solvent accessibility of peptides in
regions of the protein where the backbone is either particularly
mobile or significantly different in conformation than observed
in the pre- or postfusion atomic structures. Differences in FPOP
oxidation between the prefusion and postfusion states suggest that,
in general, regions of prefusion PIV5 F-GNCt are more dynamic
and flexible than predicted by simulations based on crystal struc-
ture, especially in the central portion of the globular head (Fig. 2 B
and C, black arrowheads).
Triggering the Refolding Reaction Using Temperature.To use heat as
a surrogate for receptor-dependent triggering by HN, we modi-
fied the FPOP experimental setup (53) to include a heating
chamber (Fig. S1). The fused silica capillary carrying the FPOP
reaction mixture to the excimer laser was extended and passed
through the heating chamber so that the protein solution was
heated for 20 s before encountering the pulsed beam of the laser.
Although the total duration of F protein-mediated refolding is
not known, a 20-s heat pulse was selected based on the kinetics
of previous fluorescence dye transfer assays with PIV5 F (33, 54)
and the timing of single-particle fusion events of influenza viri-
ons (55–57). To trigger F protein refolding, the intermediate
temperatures of 45 °C, 55 °C, and 65 °C were chosen based on
EM observation of F prefusion and postfusion states after heating
(28), indicating that PIV5 F-GCNt can be triggered by temper-
atures between 50–55 °C.
To confirm that F-GCNt was converted to the postfusion
conformation in the modified FPOP setup, electron micrographs
were taken of negatively stained protein from control samples
that were run through the FPOP apparatus but not exposed to
the laser (Fig. 3 A–E). More than 300 trimers from four to eight
fields of view for each condition were visually determined to be
in either the prefusion or postfusion state and were counted (Fig.
3F). The percentage of postfusion trimers observed increased
dramatically between 45 °C (12% postfusion trimers) and 55 °C
(86% postfusion trimers), indicating that the chosen temperature
range and duration of temperature exposure were sufficient for
F-GCNt triggering.
Monitoring F-GNCt Refolding from the Prefusion to Postfusion State.
To analyze the conversion of F-GCNt from the prefusion to the
postfusion state, the percentage of FPOP oxidation of protein
regions represented by tryptic peptides was calculated for pre-
fusion F-GCNt exposed to a range of temperatures: 21 °C pre-
fusion, 45 °C, 55 °C, and 65 °C. F-GCNt that previously had been
converted to the postfusion state also was labeled at 21 °C for
comparison. Nine peptides (comprising almost 40% of the pri-
mary sequence) predicted to be involved in the refolding process
were analyzed (Fig. 4). These peptides include the HRA/HRC
segments and the hydrophobic FP in DIII (Fig. 4A), the HRB
segment of the protein stalk (Fig. 4B), and the Ig-like Domain II
(DII) (Fig. 4C).
The exposure and extension of the FP toward the target
membrane is a critical and irreversible step in the F protein-
refolding event. The hydrophobic character of the FP, combined
Fig. 2. FPOP labeling of prefusion and postfusion PIV5 F-GCNt. (A) Com-
parison of the extent of oxidative modification observed in the tryptic
peptides of PIV5 F-GCNt labeled in either the prefusion (red bars) or post-
fusion (blue bars) conformation. Error bars represent ±1 SEM. P values were
calculated using an unpaired Student t test and corrected for multiple hy-
pothesis testing using the Benjamini–Hochberg method (*P < 0.05; **P <
0.01; ***P < 0.001; otherwise, P > 0.05). (B and C) The FPOP oxidation data
mapped onto the prefusion PIV5 F crystal structure (B) and postfusion ho-
mology structure (C). B factor values in the .pdb files were replaced by the
corresponding background-subtracted FPOP oxidation values for each tryp-
tic peptide, and one protomer for each was modeled using the Pymol preset
“B factor putty.” Peptides with the highest oxidation are depicted with thick
red tubing; peptides with low oxidation are depicted with thin blue tubing.
The other two protomers in each trimer are represented as ghosted surfaces
for clarity. The hydrophobic FP is indicated in B and C by a black arrow.
Peptides in the center of the globular head that undergo a dramatic de-
crease in oxidation between the prefusion and postfusion states are in-
dicated by black arrowheads.
Fig. 3. EM of PIV5 F-GCNt samples subjected to 21 °C, 45 °C, 55 °C, or 65 °C
temperatures for 20 s. (A–E) Prefusion F-GCNt protein was exposed to
heating in the presence of H2O2 for 20 s, as in the FPOP labeling experiment,
but without laser exposure. The prefusion and postfusion samples were both
exposed to 21 °C (room temperature). (F) Approximately 300 trimers were
counted from four to eight fields of view for each sample condition and
plotted as the percentage of total trimers that were postfusion trimers. Error
bars represent ±1 SD. P values were calculated using a two-tailed Student
t test (**P < 0.01; ***P < 0.001; n.s., not significant).
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with its accessibility upon triggering, makes it an ideal target for
FPOP labeling because of the increased reactivity of the free
radicals with aliphatic side chains (58). Thus, we predicted that
triggering F-GCNt would result in an increase in oxidation of the
FP. Indeed, FP FPOP oxidation increased dramatically in sam-
ples heated for 20 s at 55 °C as compared with samples heated
for 20 s at 45 °C (Fig. 4A, peptide 103–129 in red). A triggering
temperature between 45 °C and 55 °C matches the transition
from predominantly prefusion trimers to predominantly post-
fusion trimers observed in the electron micrographs (Fig. 3 B, C,
and F). Taken together, these data suggest that the changes in
the oxidation of the FP between 45 °C and 55 °C accurately re-
flect the triggering of the F protein.
Peptides 79–91, 130–141, and 147–186 are located in DIII of
the globular head of PIV5 F and, along with the FP, participate
extensively in the refolding event. Peptide 147–186 (Fig. 4A, in
purple) comprises a large portion of HRA and exhibits labeling
patterns that differ remarkably from the FP oxidation trend. The
oxidation of peptide 147–186 decreased significantly, from ∼9%
in the prefusion and 45 °C samples to 2.8% in the postfusion
samples. This decrease in oxidation reflects the decreased side-
chain solvent accessibility as the peptide refolds from a broken
series of α-helices, β- strands, and loops (Fig. 4A, Prefusion Inset)
to the extended α-helix that forms the core of the very stable
postfusion 6HB (Fig. 4A, Postfusion Inset and Fig. 1C). Notably,
after correcting the false discovery rate from multiple hypothesis
testing, peptide 79–91 (Fig. 4A, in blue) along with a part of
heptad repeat C (HRC) and peptide 130–141 (Fig. 4A in green)
are the only peptides analyzed that exhibited a statistically sig-
nificant pretriggering increase in oxidation upon heating to 45 °C.
Although small in magnitude because of peptide size and
amino acid composition, this increase in oxidation suggests that
these regions experience a change in solvent accessibility in their
immediate environment before the nearby FP is released and the
refolding event commences. However, after this initial change,
peptides 79–91 and 130–141 show no change in oxidation from 45
°C→ 55 °C→ 65 °C, suggesting that their helical conformations
are maintained throughout the refolding process.
Previous data from peptide inhibition studies suggested that,
in the presence of HN, the stalk of PIV5 F melts before the FP is
extended (48). However, no significant increase in the oxidation
of HRB peptides 436–458 and 459–480 (Fig. 4B, in blue and red,
respectively) occurred upon heating the prefusion protein to 45 °C.
Peptide 436–458 exhibited a progressive increase in oxidation
from 45 °C to 65 °C, consistent with temperature-dependent
stalk melting, but the FPOP oxidation decreased as the final
postfusion structure formed. The stabilizing effect of GCNt was
observed in the oxidation trend of HRB peptide 459–480, which
is closest to the C-terminal trimerization tag and did not expe-
rience significant changes in oxidation over the temperature
Fig. 4. Tracking changes in peptide FPOP oxidation over the prefusion to postfusion refolding event. The FPOP oxidative modification of multiple regions of
PIV5 F-GCNt at 21 °C, 45 °C, 55 °C, and 65 °C was determined. (Left) Wide views of the prefusion crystal structure. (Right) Postfusion homology model. For each
structure, one protomer is represented as a wheat-colored cartoon, and the other two protomers are represented as gray ghosted surfaces for clarity. Insets
with the peptides under analysis are colored according to the center column and are located immediately to the left and right of the data (prefusion and
postfusion, respectively). (A) Analysis of four peptides in DIII: a portion of HRC (peptide 79–91, blue triangles), the FP (peptide 103–129, red diamonds), and
HRA [peptides 130–141 (green squares) and 147–186 (purple circles)]. A dramatic increase in FP oxidation is observed between 45 °C and 55 °C, corresponding
to temperature-induced protein triggering. (B) Melting of the prefusion stalk is seen primarily in peptide 436–458 (blue triangles), which comprises the top of
HRB. The stabilizing influence of the C-terminal GCN trimerization domain is seen in the minimal change in oxidation values for peptide 459–480 (red
diamonds). (C) Three peptides comprise almost all the Ig-like DII. Peptides 369–381 (blue triangles) and 410–419 (green squares) exhibit very little change in
FPOP labeling over the temperature range, whereas peptide 387–409 (red diamonds) on the outside of DII exhibits a dramatic decrease in oxidation. Because
there is very little change in overall domain conformation between the two states, the decrease in FPOP labeling for peptide 387–409 suggests a decrease in
flexibility for this peptide. Error bars represent ±1 SEM.















range. Unlike soluble F-GCNt, WT PIV5 F is anchored to the
membrane via a transmembrane domain and can be triggered to
refold by heating to 42 °C in transfected tissue culture cells (24).
Because 42 °C is lower than the triggering temperature of 45–55 °C
observed in this study for soluble F-GCNt, these observations
suggest that the GCN tag has a greater stabilizing effect on the
prefusion state than do the transmembrane domain and cyto-
plasmic tail of WT PIV5 F. Therefore, the apparent lack of in-
creased stalk flexibility in F-GCNt cannot be assumed to be true
for WT PIV5 F protein.
The Ig-like DII domain was predicted previously to move
through the refolding event as a rigid module (41). Surprisingly,
peptide 387–409, on the outer surface of DII, exhibited a notable
decrease in oxidation upon F triggering (Fig. 4C, in red). Mu-
tagenesis studies have implicated this region as being important
for the interactions of both PIV5 F (59) and MeV F (60) proteins
with their attachment proteins, HN and H, respectively, sug-
gesting that this change in the flexibility of peptide 387–409 in
PIV5 F protein has functional significance for interacting with
the attachment protein. The inner surface of DII, created by
residues contained in peptides 369–381 and 410–419, provides
the hydrophobic surface that sequesters the FP between DII of
one protomer and DIII of the neighboring protomer (Fig. S5).
Exposure of this hydrophobic surface to solvent during the re-
folding event would be expected to result in an increase in oxi-
dative labeling for these peptides, similar to that observed for the
FP. However, oxidation of these two peptides remained constant
over all labeling conditions (Fig. 4C, in blue and red), suggesting
that their solvent accessibility does not change significantly
during F protein refolding.
The crystal structures of hPIV3 (44), RSV (46, 47), and NDV
(45) F proteins in their postfusion conformations all show DII
interacting with the strap peptides that connect DI and DIII. The
strap of PIV5 F, which includes peptides 20–36, 37–52, and 273–
308 (shown in cyan, green, and yellow, respectively, in Fig. 5),
showed a notable decrease in oxidation over the tested tem-
perature range, suggesting stabilization upon protein refolding.
In particular, peptide 37–52, which transitions from being ex-
posed in the prefusion state (Fig. 5B, Inset, colored as in Fig. 5A)
to being covered by the HRB linker of a neighboring protomer in
the postfusion state (Fig. 5C, Inset), highlights this decrease. DI
strap stabilization through contact with DII is supported further
by analysis of the oxidation of DII residue D416 (Fig. 5A, in
black), which mirrored the decrease in FPOP labeling observed
in the strap peptides. The oxidation values for D416 are signif-
icantly lower than those of the strap peptides for two reasons: (i)
peptides contain many more sites of potential modification, and
(ii) the specific modification observed (−27.99 Da loss of CO)
occurs less frequently than the more common modifications.
However, the overall trend of the oxidation of D416 is the same
as observed in the strap peptides.
The simplest interpretation of these data is that, upon trig-
gering and FP release, DII collapses inward to fill the space
vacated by the FP (Fig. 5B, Inset) and interacts with the extended
β-strands of the strap peptides. This collapse would keep the
inner face of DII protected from solvent, avoiding the energet-
ically unfavorable step of solvating such a highly hydrophobic
surface. The inward collapse of DII also permits the initiation
of hydrogen bond formation between the HRB linker and the
DI/DIII strap (Fig. 5C, Inset, blue dashes, shown in more detail
in Movie S3). This initial contact would nucleate a “zippering
up” of the HRB linker backbone along the side of the globular
head through the formation of hydrogen bonds, suggesting a
mechanism to drive the resolution of the prehairpin intermediate
state. Additionally, these data suggest that the trimeric structure
of PIV5 F is maintained throughout the refolding process, in
contrast to observations for vesicular stomatitis virus G (61, 62),
a class III viral fusion protein.
Residue-Level Oxidative Footprinting of Early Changes Along the F
Protein-Refolding Pathway. When the prefusion F-GCNt protein
was heated from 21 °C to 45 °C, only two regions, represented by
peptides 79–91 and 130–141, demonstrated statistically signifi-
cant increases in oxidation at the peptide level. In addition to
being localized to DIII of the globular head, these two peptides
occupy the space immediately surrounding the FP (Fig. 6A;
peptides are colored as in Fig. 4A). To ensure high reliability, we
performed a manual analysis of the MS/MS fragmentation data
for these peptides (see Fig. S2 for a detailed example) as well as
for the FP (Fig. 6 B–D).
Within peptide 79–91, residues P82 and E88/R91 showed a
similar decreasing pattern of oxidation over the temperature
range, whereas residues L87, T89, and I90 showed increasing
oxidation. The dramatic increase in the oxidation levels of resi-
due I90 (Fig. 6B), in particular, reflects the increased solvent
accessibility in that local region upon triggering-induced FP re-
lease (Fig. 6A, Insets). Within region 130–141, the oxidation
Fig. 5. Domain II collapses inward to fill the space vacated by the FP and
interacts with the strap peptides of Domain I. (A) FPOP oxidation values for
three peptides of DI that comprise the strap connecting DI and DIII: peptide
20–36 (cyan triangles), peptide 37–52 (green diamonds), and peptide 273–
308 (yellow squares). The colors are maintained for the cartoon repre-
sentations in B and C. The FPOP oxidation value for residue D416 located in
DII of the neighboring protomer is shown as a black line without markers
and is depicted in black stick representation in B and C. Error bars for FPOP
oxidation data represent ±1 SEM. (B and C) Prefusion (B) and postfusion (C)
structures highlighting the peptides and residue from A. The strap peptides
(in cyan, green, and yellow), the FP (pink), and HRA (purple) are from one
protomer; DII (red), the HRB linker (orange), and HRB (dark blue) are from
the neighboring protomer. The remainder of the structure is ghosted for
clarity. (B, Inset) Zoomed view showing the up-and-out movement of the FP
and HRA (purple arrow) upon triggering, creating a void that is filled by the
inward collapse of DII from the neighboring protomer (red arrow). Stick
representations of residue side chains in peptide 37–52 (green cartoon) are
colored according to atom [carbon, green or orange (colored by peptide);
oxygen, red; nitrogen, blue]. These residues form an extensive series of hy-
drogen bonds with the HRB linker in the postfusion conformation (C, Inset,
blue dashes), suggesting a mechanism for driving the resolution of the
prehairpin intermediate.
E2600 | www.pnas.org/cgi/doi/10.1073/pnas.1408983111 Poor et al.
values decreased for E132 and L140, both of which are located
on the same face of the α-helix (Fig. 6 A, Inset and D). The
similar oxidation trend over the temperature range for E132 and
L140 provides further evidence that the α-helical character of
HRA in this region is maintained over the course of the refolding
event. I137 and L138, on the undersurface of the α-helix, ex-
hibited an increase in oxidation over the temperature range,
consistent with their exposure upon the release of the FP and
the extension of HRA toward the target membrane. In contrast
to peptides 79–91 and 130–141, the oxidation patterns of all
individual residues in the FP (Fig. 6C) showed the same overall
trend as the peptide-level data, indicating that all these residues
become more exposed to solvent as the FP is released from its
sequestered, prefusion conformation and is extended toward the
target membrane.
Analysis of these three peptides at the residue level revealed
that the oxidation patterns of individual amino acids can either
mirror the peptide-level pattern, as in peptide 103–129 (Fig. 6C),
or vary dramatically from the peptide-level pattern, as in peptides
79–91 (Fig. 6B) and 130–141 (Fig. 6 D). The dramatic variation
occurs when the microenvironment of individual residues differs
from the “average” value for a peptide region. For the F protein,
which is large and protease-resistant, FPOP can provide higher-
resolution dynamic structural information than could be ob-
tained with NMR or HDX-MS.
Discussion
Here we have demonstrated the ability to track conformational
changes of the soluble form of a metastable viral fusion protein
using FPOP oxidative labeling and MS. Upon initiation of the
refolding process, the hydrophobic FP is released from its se-
questered location behind the Ig-like DII of the neighboring
protomer. As the HRA segment refolds from a series of broken
α-helices and β-strands into a single, extended α-helix, it propels
the newly solvated FP toward the target membrane for insertion.
As soon as the FP is released, DII collapses inwards to fill the
void left by the FP, interacting with and stabilizing the strap
peptides of the neighboring protomer. At this extended, pre-
hairpin intermediate stage of the refolding process, DI, DII, and
DIII of the globular head have adopted their postfusion con-
formations. The interaction of DII with the strap peptides ini-
tiates a hydrogen bond-driven zippering action between the
HRB linker and the strap peptides of the globular head, leading
to a resolution of the prehairpin intermediate to the final,
stable postfusion state.
The use of heat as a surrogate trigger of the PIV5 F refolding
event allowed the monitoring of the refolding event at a pre-
viously unattainable level of structural detail. EM analysis of
negatively stained control samples established that F-GCNt ac-
tivation from prefusion to postfusion occurs between 45 °C and
55 °C (Fig. 3). A successful refolding event requires that the FP
transition from a sequestered prefusion conformation to an ex-
tended and solvated postfusion conformation. The hydrophobic
Fig. 6. Residue-level oxidative footprinting of peptides involved in early changes along the F protein-refolding pathway. (A) A trimer of PIV5 F-GCNt, with
one protomer depicted as a cartoon ribbon. Peptides 79–91 (blue), 103–129 (red), and 130–141 (green) are highlighted. The zoomed and rotated views show
the residues analyzed as sticks colored according to atom (carbon, gray; nitrogen, blue; oxygen, red) and labeled. (B–D) Traces show background-sub-
tracted percent of FPOP oxidation for resolvable residues in each peptide as well as the sum of the individual residue oxidations (“total”). Error bars
represent ±1 SEM.















character of the FP makes it an ideal target for FPOP labeling,
and its triggering-induced exposure between 45 °C and 55 °C was
shown (Fig. 4A). The absence of increased oxidation for peptides
369–381 and 410–419 (Fig. 4C), which sequester the FP in the
prefusion state, indicates that the inner surface of DII is not
exposed to solvent upon triggering, suggesting that dissociation
of the trimer is not required for the successful refolding of PIV5
F-GCNt. Further analysis of residue D416 in DII revealed a de-
crease in oxidation that mirrored the decreased oxidation in the
strap peptides connecting DI and DIII (Fig. 5A). This de-
creased oxidation is consistent with the interprotomer inter-
action of these two parts of the protein in the postfusion state
and suggests that DII collapses inward to interact with the strap
peptides as soon as the FP is released upon protein triggering.
The contact between DII and the strap peptides upon activation
brings the N-terminal end of the HRB linker into close proximity
with the strap peptides, permitting the initiation of a hydrogen
bond zippering event of the linker up the side of the globular
head and leading to the resolution of the prehairpin inter-
mediate state. Ultimately this process leads to the juxtaposi-
tion of HRB with the extended HRA coiled-coil and provides
a mechanism for the events immediately prior to the formation
of the 6HB and membrane fusion.
We also show that global oxidation levels of PIV5 F-GCNt
decrease upon refolding from the prefusion to the postfusion
state. Additionally, the SASA for tryptic peptides of PIV5 F-
GCNt in the prefusion and postfusion conformations were cal-
culated from MD simulations of available crystal structure data.
By comparing the changes in FPOP modification with the cal-
culated SASA, we can localize changes in the protein between
the prefusion and postfusion states. Differences in free radical
reactivities among amino acids make comparisons of both
interpeptide and oxidation/SASA raw values difficult. We limit
our comparison to the net change from prefusion to postfusion
for individual peptides, making the reasonable assumption that
the total reactivities of each peptide are the same across the
analysis. When the net change in FPOP oxidation (percent oxi-
dation in prefusion − percent oxidation in postfusion) is com-
pared with the net change in SASA (SASA prefusion − SASA
postfusion), different trends emerge for many of the peptides.
Of the tryptic peptides contained in both models, 10 of the 17
peptides (Fig. 7A, highlighted in pink) demonstrate a change in
FPOP labeling different from that predicted by changes in the
side-chain SASA of the static crystal structures alone (e.g., pre-
fusion > postfusion vs. prefusion = postfusion). Experimental
FPOP values that deviate from the values predicted from the
side-chain SASA calculations suggest that the static crystal
structure data do not accurately reflect the flexibility of one or
both of the states. Nine of these 10 peptides have larger, more
positive (i.e., prefusion > postfusion) experimental ΔFPOP val-
ues, suggesting that the solvent accessibility calculated from the
MD simulations either underestimates the prefusion SASA or
overestimates the postfusion SASA. Given that (i) there is very
little structural variation between the postfusion structures of
multiple paramyxovirus F proteins; (ii) the postfusion state is
a highly stable conformation that represents an energy minimum
for the protein; and (iii) there is variation in the two prefusion
crystal structures of paramyxovirus fusion proteins (PIV5 F and
RSV F), we attribute most of the disagreement in the ΔFPOP/
ΔSASA trend to an underestimation of the prefusion SASA
calculation. Thus, the lopsided distribution of these nine
peptides likely reflects the global decrease in flexibility of
the postfusion state relative to the prefusion state. Further,
FPOP labeling that deviates from expected SASA trends
may highlight regions of greatest solvent accessibility and
protein movement.
Interestingly, most of the nine peptides that show ΔFPOP
values differing from the ΔSASA values contain the epitopes
of prefusion-specific neutralizing antibodies that have been dis-
covered for a range of paramyxovirus F proteins (Fig. 7 A and B).
The epitopes of D25 (α-RSV F Fab) (43), MPE8 (broadly neu-
tralizing against hRSV and hMPV) (63), DS7 (α-hMPV F Fab)
(64), F1a (α-PIV5 F Mab) (65), and 05D (α-PIV5 F Fab) are
colored according to the ovals at the bottom of Fig. 7A and
mapped onto their homologous sequences in the prefusion PIV5
F atomic structure (Fig. 7B). Peptide 387–409 of PIV5 F (Fig. 7
Fig. 7. Changes in peptide FPOP oxidation and side-chain SASA between the prefusion and postfusion states. (A) Postfusion FPOP or SASA values are
subtracted from the corresponding prefusion FPOP or SASA values for the tryptic peptides that are common between the two states and graphed. The data
represent the change in FPOP oxidation or side-chain SASA between the prefusion and postfusion states. Peptides that exhibit a different ΔFPOP trend
compared with ΔSASA are highlighted by pink backgrounds. The backbone of the cartoon trimer in B is colored similarly. At the bottom of A, the epitopes of
prefusion-specific, neutralizing antibodies against various paramyxoviruses and the HN-interacting surface of PIV5 F are assigned to their homologous PIV5 F
tryptic peptides. These important epitopes and interaction surfaces are represented as semitransparent surfaces in B, colored according to the ovals at the
bottom of A. The distribution of epitopes and surfaces to peptides that show greater-than-expected ΔFPOP values (relative to ΔSASA) is not random (P =
0.0023, one-tailed Fisher’s exact test), suggesting a correlation between regions of increased prefusion FPOP oxidation and functionally important parts of the
metastable prefusion trimer.
E2602 | www.pnas.org/cgi/doi/10.1073/pnas.1408983111 Poor et al.
A and B, cyan surface) contains residues that have been impli-
cated in the interactions between PIV5 F and HN proteins (59)
and between MeV F and H proteins (60) as well as being ho-
mologous with antigenic site IV of the RSV F protein. The ex-
tensive overlap between antigenically or functionally significant
regions of paramyxovirus fusion proteins and PIV5 F-GCNt
peptides with greater-than-predicted levels of FPOP oxidation in
the prefusion state is not random (P = 0.0023, one-tailed Fisher’s
exact test) and suggests that there is a correlation between
flexibility and functionality for these metastable proteins. Bind-
ing of neutralizing antibodies to these regions in paramyxovirus F
proteins could stabilize the flexibility of these dynamic regions in
the prefusion state or sterically interfere with the refolding event.
This study highlights the need to view paramyxovirus F pro-
teins as highly dynamic molecular machines. Correlation with the
reported epitopes of neutralizing antibodies against other para-
myxoviruses suggests that regions of viral fusion proteins ex-
periencing larger changes in FPOP labeling than would be
predicted from the static crystal structure data may be important
for proper protein function and thus make good targets for
the development of neutralizing antibodies or small-molecule
inhibitors. FPOP is shown to be useful as a medium resolution
technique for the study of transient protein conformations along
a complex refolding event as well as a method for probing the
dynamic movement of a protein under physiologic conditions.
We suggest that FPOP results can provide the dynamic structural
insights necessary for guiding more targeted and efficient ap-
proaches to antiviral therapeutic development. Furthermore,
FPOP can provide dynamic structural information for pro-
teins and complexes that would not be amenable to study by
other structural techniques and thus is of interest to the broader
scientific community.
Materials and Methods
Cells. Insect High Five cells (Invitrogen) were maintained in Express 5 serum-
free medium (Gibco) supplemented with 10% (vol/vol) GlutaMax (Gibco)
and 1% penicillin/streptomycin. Insect Sf9 cells used for generating
baculovirus stocks were maintained in SF900 II medium (Invitrogen) sup-
plemented with 10% (vol/vol) FBS and 1% penicillin/streptomycin.
Protein Purification. Soluble PIV5 F-GCNt was purified from High Five insect
cells expressing F-GCNt as described previously (41, 42). Briefly, High Five
insect cells were infected at a multiplicity of infection of ∼2 pfu per cell with
a recombinant baculovirus that expresses F-GCNt. At 48 h postinfection, the
medium was harvested, and soluble F-GCNt protein was purified by affinity
chromatography using Ni-NTA resin (Qiagen). The purified F-GCNt was
>90% pure by SDS/PAGE gel analysis and silver staining. The protein was
buffer exchanged into 300 mM NaCl, 10 mM sodium phosphate (pH 7.4)
using 10-kDa molecular weight cut off (MWCO) Amicon Ultra concentrator
centrifuge tubes (Millipore). F-GCNt was concentrated to a final concentra-
tion of 10 mg/mL and stored at 4 °C until use. The time elapsed between
protein purification and oxidative labeling was minimized to reduce the
stochastic conversion of prefusion F-GCNt to the postfusion state.
EM. EM images were prepared as described previously (27).
FPOP. Hydrogen peroxide (H2O2) (30%), formic acid, PBS, L-glutamine, and
L-methionine were obtained from Sigma-Aldrich. The FPOP labeling protocol
was modified from that previously described (52, 53, 66–69). The FPOP
method uses a KrF excimer laser to generate 248-nm wavelength laser pulses
to photolyze molecular H2O2 into •OH radicals that covalently modify
solvent-exposed side chains of amino acids (described in refs. 52, 53, and 66–
70). Unlike the deuterium incorporation in HDX-MS, the rate of free radical
modification in FPOP varies among amino acids (reviewed in ref. 58), with
14–16 of the 20 amino acids being irreversibly modified on the time-scale of
most FPOP experiments (53). Aliphatic side chains have been shown to be
the most reactive (58). The covalent nature of the hydroxyl radical foot-
printing label permits label localization down to the peptide, subpeptide,
and even amino acid level of resolution using commonly available MS
peptide fragmentation modalities such as collision-induced dissociation (CID)
and higher-energy C-trap dissociation used in proteomics studies. FPOP has
an additional advantage over HDX-MS because the covalent modifications
do not suffer from the back-exchange and label scrambling that occurs with
deuterium labeling and collisional activation in MS/MS. Thus, FPOP permits
delayed and careful sample workup before MS analysis, including deglyco-
sylation and in-gel proteolysis of difficult-to-digest proteins.
In this modified protocol, 1 μM F-GCNt and 20 mM glutamine in a total
volume of 150 μL PBS in 1.5-mL Eppendorf tubes were kept on ice until use.
Immediately before labeling, 0.5 M H2O2 was added to a final concentration
of 60 mM, and the samples were vortexed briefly, spun down, and loaded
into a 250-μL Hamilton syringe. Samples with a 20% exclusion volume
fraction (the volume not irradiated) were infused through fused silica tubing
(150-μm i.d.) at a rate of 30.4 μL/min and irradiated using an excimer laser
pulse frequency of 15 Hz and a laser power of 47.24 mJ (Fig. S1). Labeled
samples were collected in Eppendorf tubes containing 30 μL of 200 mM
L-methionine and 3 μL of 1 mg/mL catalase to eliminate any residual free
radicals and unreacted molecular H2O2.
Five independently mixed protein samples were labeled for each tem-
perature condition. Three control samples for each conditionweremadewith
H2O2 but were not exposed to laser irradiation. Final FPOP percent oxidation
values were calculated by subtracting the averaged oxidation value of the
control samples from those of the labeled samples exposed to the laser. All
prefusion and postfusion F-GCNt samples were FPOP-labeled at 21 °C. To
perform the temperature labeling experiments, the length of the fused silica
capillary was increased so that 57 cm of capillary lay within a heating
chamber that was contiguous with the laser window (Fig. S1). Based on flow
rate and capillary i.d., the solution flowing through the capillary was ex-
posed to the temperature for ∼20 s before passing the laser window. The
stated temperatures within the heating chamber were maintained at ±1 °C
for the duration of the labeling experiment.
Sample Preparation and MS. Samples were concentrated using 0.5-mL 10-kDa
MWCO Amicon Ultra concentrator tubes (Millipore) to reduce the total
volume to ∼20–30 μL. Samples then were deglycosylated using Peptide-N-
Glycosidase F (New England BioLabs) according to the manufacturer’s pro-
tocol. Briefly, 10X Glycoprotein Denaturing Buffer (5% SDS, 0.4 M DTT) was
added according to sample volume. The samples were heated briefly (3 min.)
at 90 °C to encourage denaturing while minimizing heating-induced oxi-
dation. Then 10X G7 Reaction Buffer [500 mM sodium phosphate (pH 7.5) at
25 °C] and 10% Nonidet P-40 were added in amounts scaled to the total
volume of each sample, and 2 μL (1,000 U) of PNGase F enzyme was added.
Samples were incubated overnight at 37 °C to maximize deglycosylation.
Note: Because deglycosylation with PNGase F results in the conversion of
asparagine to aspartic acid and because not all asparagine residues in
N-linked glycosylation sites are glycosylated, the values for the percent
of FPOP oxidation were calculated for both species of peptide and were
added together.
Deglycosylated samples were denatured and size fractionated using a
reducing 15% SDS/PAGE gel. Deglycosylated protomers of F-GCNt migrate
at ∼50 kDa. The dye front of the gel was run ∼3 cm into the resolving gel to
separate the residual PNGase F (∼36 kDa) and the catalase (∼60 kDa per
monomer). Linearized F-GCNt then was excised as a gel band and subjected
to overnight in-gel trypsin digestion (Worthington) according to the Uni-
versity of California, San Francisco in-gel digest protocol (http://msf.ucsf.edu/
ingel.html). The collected tryptic peptides for each sample were collected in
LoBind Eppendorf tubes, and the total volume was reduced to ∼20 μL using
a speed vac (Savant). Samples were acidified to 5% formic acid.
Samples were analyzed on an LTQ Orbitrap XL operated in data-dependent
acquisition mode controlled by Xcalibur 2.0.7 software (Thermo Fisher).
Samples were in-line desalted for 5 min using a 100 μm × 2 cm Acclaim
PepMap100 C18 nano trap column (5 μm, 100 Å) (Thermo Scientific) with
a Dionex UltiMate 3000 liquid chromatograph (Thermo Scientific) at 8 μL/
min. After desalting, the peptides were eluted onto and separated using
a custom-packed C18 reverse-phase column (Magic, 0.075 mm × 100 mm,
5 μm, 120 Å; Michrom Bioresources, Inc.). Peptides were eluted at 260 nL/min
using the following gradient: 0–60% solvent B (20% water, 80% acetoni-
trile, 0.1% formic acid) for 110 min., then to 90% solvent B for 10 min., and
then re-equilibrated to solvent A (water, 0.1% formic acid) for 10 min. Blank
injections were run between each sample to minimize carryover between
runs. Peptide mass spectra were acquired over an m/z range of 350–2,000 at
high mass resolving power (60,000 for ions of m/z 400). The six most abun-
dant ions with a charge of at least +2 and with a minimum signal intensity
of 500 were subjected to CID in the linear ion trap, with data-dependent
scanning. Ions with a charge-state of +1 were rejected. Tryptic digestion of
F-GCNt and MS analysis showed a minimum of 94% sequence coverage of F
protein for each sample.















Data Analysis. The oxidation of each tryptic peptide was calculated as a
percentage of the total peptide by area under the curve (AUC) analysis of the
extracted ion chromatograms using the ProtMapMS analysis software
(NeoProteomics). (See Fig. S2 for a detailed example.)
The .raw files were imported into ProtMapMS, converted to .mzXML files,
and analyzed. The following program settings were used: retention time,
20–140 min; peptide mass range, 500–8,000 Da; charge states,1–6; protease,
trypsin; missed cleavages, 1; MS1 error tolerance, 8 ppm; MS2 error toler-
ance, 0.45 Da; m/z width for SIC integration, 10 ppm. Identified oxidation
species were validated manually using custom Microsoft Excel macros writ-
ten in Visual Basic. The areas under validated selected ion chromatogram
curves were exported into Excel and used to calculate percent oxidations by
adding up the AUC of all identified oxidized products, dividing them by the
total AUC of oxidized+unmodified products, and then multiplying by 100.
Only values normalized against the unmodified peptide intensities were
compared between samples to correct for differences in the concentrations
of injected sample. FPOP labeling was done in biological quintuplicate (five
independent laser reactions) and analyzed in technical duplicate (two sep-
arate injections per biological replicate) on the mass spectrometer. Control
samples were labeled in biological triplicates (except for the postfusion
control condition, which was run in duplicate), but only a single injection per
biological replicate was run on the mass spectrometer because of instrument
time constraints. AUC analysis was carried out independently for all bi-
ological and technical replicates. Technical replicate values were averaged,
and then biological replicates were averaged and SDs and SEMs were cal-
culated. Python and R were used to calculate P values from an unpaired
Student’s t test, and these values were adjusted using the Benjamini–
Hochberg method (71) to control the false discovery rate caused by multiple
hypothesis testing. Comparisons were made between conditions but never
directly between different peptides because of variations in peptide amino
acid composition (and, thus, peptide free radical reactivity). Error bars in all
FPOP graphs represent ±1 SEM unless otherwise specified.
Because of the metastable nature of prefusion F-GCNt, a small amount of
every prefusion F-GCNt protein preparation always converts to the postfusion
state. The EMs of the prefusion condition were used to determine that ∼7%
of the “prefusion” sample actually was postfusion protein. The percent
oxidation values of the prefusion samples were corrected for this postfusion
“contamination.”
Molecular Dynamics Simulation and Calculations of SASA. Preparation of pre-
and postfusion protein structures. A crystal structure of the PIV5 F protein in its
prefusion conformation (PDB ID code 2B9B) was reported at 2.85-Å resolution
and was used in this analysis. All the crystallized ligands (N-acetyl-D-glucos-
amine) and water molecules were removed. All histidine residues were
considered as neutral with a hydrogen atom on the epsilon nitrogen. Be-
cause no structure for the postfusion state of PIV5 F is available, a homology
model was generated using the SWISS-MODEL (72) homology modeling
server with the hPIV3 postfusion crystal structure (PDB ID code 1ZTM) as
template (22% identity, 65% similarity, and Evalue = 3 × 10
−115). A sequence
41 residues long and consisting of the hydrophobic FP was unresolved in the
hPIV3 F structure, indicating that it does not adopt a defined conformation.
To avoid biasing the model by introducing this peptide in a single, possibly
irrelevant, conformation, this sequence also was omitted from the homol-
ogy model, necessitating the use of backbone restraints in subsequent
simulations. The terminal residues at the location of the missing loop were
capped with N-methyl (NME) and N-acetyl (ACE) groups as appropriate. To
check the quality of the modeled and template structures, z-scores of the
backbone conformations were calculated using WHATIF (73). Both the
template and the model received acceptable z-scores of 1.2 and 0.7, re-
spectively. It is well established that class I fusion proteins share structural
features without having high sequence similarity; therefore, the model
generated was accepted as is and was used for further analysis.
Energy minimization. Each protein structure was solvated in a truncated oc-
tahedral box of TIP3P water molecules (74), with counter ions (Na+) added to
neutralize the charge, using the tLEAP module of AMBER. For the prefusion
structure, 97,332 water molecules were required, whereas the postfusion
required 110,360. The simulations were performed using AMBER12 force
field (75) with ff99SB parameters (76), with a cutoff for nonbonded inter-
actions of 10 Å. To remove bad contacts, the system was minimized in two
steps. First, the energy of the water and ions was minimized while keeping
all protein atoms restrained (500 kcal−1·mol−1·Å2). This step was followed by
energy minimization of the entire system. Each minimization comprised an
initial phase of steepest descent method for 5,000 steps, followed by con-
jugate gradient for 20,000 steps. The resulting minimized structures were
subjected to MD simulation performed with the pmemd.cuda version of
AMBER12 (77).
MD simulation. All the bonds involving hydrogen were constrained using the
SHAKE algorithm, enabling an integration time step of 2 fs. Long-range
electrostatic interactions were treated with the Particle-Mesh Ewald algo-
rithm (78), with a long-range nonbonded interaction cutoff set to 10 Å. The
systems were heated from 5–300 K over a span of 50 ps, under constant
number, volume, and temperature conditions using the Berendsen ther-
mostat with a coupling time constant of 1 ps. The simulation then was
continued for 10 ns under base pressure and temperature conditions with
weak restraints on the backbone atoms (100 kcal−1·mol−1·Å2). The first 1 μs
of this trajectory was discarded before analysis of the equilibrated data.
Data analysis. SASA values were computed with the NACCESS (79) program
for snapshots collected every 10 ps. Average values were computed from
the total 900 snapshots. Error bars on SASA data graphs represent ±1 SD.
Modeling of the Data. The B factor values in the prefusion PIV5 F (PDB ID
code 2B9B) and the postfusion homology structure were replaced by percent
oxidation values for the corresponding peptides. Protein imageswere created
using the Pymol modeling program (80).
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